A group of medical researchers working at Georgetown University, the University of Rochester and UC-Irvine have developed a blood test which predicts with 90 percent accuracy if an individual will develop Alzheimer’s disease or mild cognitive impairment (MCI) within three years. The test, which looks for a set of ten lipid markers, will allow treatments to be sought that may be effective during this early, asymptomatic stage of the disease.
via Gizmag
Image: US National Institutes of Health
 Want early design analysis without simulation?Sponsored by Siemens Digital Industries Software Traditional verification methods are failing today's complex IC designs, which require a proactive, early-stage analysis approach. A shift-left methodology addresses IP block integration challenges and the limitations of traditional simulation and ERC tools. Insight Analyzer detects hard-to-find leakage issues across power domains, enabling early analysis without full simulation. Identify inefficiencies earlier to reduce rework, improve reliability, and enhance power performance. |
